• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Matrix Gla protein (MGP)

Amino acids 20-96 form the expressed segment for recombinant Human MGP. The expected molecular weight for the MGP protein is calculated to be 13.5 kDa. This MGP recombinant protein is manufactured in e.coli. The MGP gene fragment has been modified by fusing the N-terminal 6xHis tag, providing convenience in detecting and purifying the recombinant MGP protein during the following stages. Human matrix gla protein (MGP) is a vital extracellular matrix protein that plays a key role in preventing vascular calcification. Primarily synthesized by vascular smooth muscle cells and chondrocytes, MGP is known for its ability to inhibit the deposition of calcium in soft tissues, including blood vessels and cartilage. As an antagonist of vascular calcification, MGP helps maintain vascular elasticity and integrity. Dysregulation of MGP has been linked to arterial stiffness and cardiovascular diseases. Research on MGP encompasses cardiovascular health, bone metabolism, and tissue mineralization, emphasizing its significance in understanding and potentially treating conditions related to ectopic calcification and maintaining tissue homeostasis. ?

ACP02598

Amino acids 20-96 form the expressed segment for recombinant Human MGP. The expected molecular weight for the MGP protein is calculated to be 13.5 kDa. This MGP recombinant protein is manufactured in e.coli. The MGP gene fragment has been modified by fusing the N-terminal 6xHis tag, providing convenience in detecting and purifying the recombinant MGP protein during the following stages.

Human matrix gla protein (MGP) is a vital extracellular matrix protein that plays a key role in preventing vascular calcification. Primarily synthesized by vascular smooth muscle cells and chondrocytes, MGP is known for its ability to inhibit the deposition of calcium in soft tissues, including blood vessels and cartilage. As an antagonist of vascular calcification, MGP helps maintain vascular elasticity and integrity. Dysregulation of MGP has been linked to arterial stiffness and cardiovascular diseases. Research on MGP encompasses cardiovascular health, bone metabolism, and tissue mineralization, emphasizing its significance in understanding and potentially treating conditions related to ectopic calcification and maintaining tissue homeostasis.

?

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02598 Target NameMGP
Target SynonymsCell growth inhibiting gene 36 protein; Cell growth-inhibiting gene 36 protein; GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, MATRIX; GIG36; Matrix Gla protein; MGLAP; MGP; MGP_HUMAN; NTIFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range20-96aa
Mol Weight13.5kDaProtein LengthFull Length of Mature Protein
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP08493
Background Information
  • Uniprot Id

    P08493

  • Target Species

    Human

  • Target Name

    MGP

  • Target Full Name

    Matrix Gla protein

  • Target Function

    Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation.

  • Target Involvement

    Keutel syndrome (KTLS)

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Osteocalcin/matrix Gla protein family

  • Target Research Area

    Developmental Biology, Signal Transduction

  • Target Synonyms

    Cell growth inhibiting gene 36 protein; Cell growth-inhibiting gene 36 protein; GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, MATRIX; GIG36; Matrix Gla protein; MGLAP; MGP; MGP_HUMAN; NTI

  • Target Background

    This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia.

Inquire Recombinant Human Matrix Gla protein (MGP) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification